Transdermal patch is a pharmaceutical paste patch that
is positioned on the skin to transport a special amount of medicine
through the skin into the blood circulation hence make it non- invasive way of
drug delivery. Global transdermal drug delivery market was estimated at USD
22.0 Billion in 2010 and reached to at USD 32.0 Billion in 2015, registering a
compound annual growth rate (CAGR) of 8.0%.
Market
Segmentation
By Application
Based on the application, global transdermal drug
delivery market is segmented are as follows:
Cardiovascular
CNS
Hormone
Pain Management
Others
By
Technology
While studying the global transdermal drug delivery
market, we had segregated the market into:
Electric current
Electroporation
Lontophoresis
Mechanical arrays
Microporation
Radio Frequency
Thermal
Ultrasound
By Region
On the basis of region, the global transdermal drug
delivery market is segmented into:
North America
Latin America
Western And Eastern Europe
Asia-Pacific
Row (Rest Of World)
Growth
Drivers and challenges
On the back of factors like rising number of
transdermal drug delivery products, enhanced awareness in developed nations
about non-invasive way of drug administering drugs into body, increasing demand
owing to its convenience over other conventional methods for supervising drugs
etc. the transdermal
patch drug delivery market is expected to have a greater demand in near
future.
In addition to that, steep rise in diabetic population
across the globe, advancement of technology in transdermal drug delivery and
rise in the personal disposable income across the world are the factors which
are anticipated to drive the growth of global transdermal drug delivery market
during the forecasted period i.e. 2015-2021.
The global transdermal drug delivery market is
restraint by high cost of the product, lack of awareness among in the
developing and under-developed countries and availability of various
alternatives in the market.
Market Size
and Forecast
Global transdermal drug delivery market is estimated
at USD 30.3 Billion in 2015 with 12.6% share accounted to the U.S. only;
biggest market for transdermal drug delivery in the region. North American
total drug delivery market was estimated at USD 518.2 Billion in 2015 and is
anticipated to reach USD 752.6 Billion by 2021. Owing to rise in the demand of
innovative drug delivery market in this region and growing acceptance of drug
delivery technology by pharmaceutical and medical device companies are few of
the factors that are projected to drive the transdermal patch drug delivery
market in North America.
The European total drug
delivery market was valued at USD 39.9 Billion in the year 2012 and it is
anticipated that the transdermal drug delivery market will grow at a healthy
rate over the forecasted period i.e. 2015-2021 owing to the increasing demand
for self-administration and home healthcare devices.
Asia pacific transdermal drug delivery market is
projected to grow at a substantial rate owing to a steep rise in medical
tourism in the region, world-class medical facilities and medical procedures at
a low cost, rising incidents of chronic diseases like cardiovascular diseases,
diabetes, cancer etc.
Key Players
The key player of the global transdermal drug delivery
market is as follows:
ANI Pharmaceuticals Inc.
Antares Pharma Inc.
Bayer AG
Janssen Pharmaceuticals Inc.
Novartis AG
Scope and Context
Overview of the Parent Market
Analyst View
Market Size and Growth
North America (U.S., Canada)
Latin America (Mexico, Brazil, Rest of Latin America)
Western and Eastern Europe (Germany, Italy, Spain,
France, U.K, Benelux, Hungary, Rest Of Western Europe, Russia Poland, Rest of
Eastern Europe)
Asia-Pacific (China, India, Singapore, Japan,
Australia & New Zealand & Rest of Asia)
Middle East and North Africa (MENA)
Rest of World
Segmentation
By Application
By Technology
By Region
Market Dynamics
Supply & Demand Risk
Competitive Landscape
Porter’s Five Force Model
Geographical Economic Activity
Key Players (respective SWOT Analysis) and their
Strategies and Product Portfolio
Recent Trends and Developments
Industry Growth Drivers and Challenges
Key Information for Players to establish themselves in
current dynamic environment
To know more about this research, kindly
visit: http://www.researchnester.com/reports/global-transdermal-drug-delivery-market-analysis-opportunity-outlook-2021/111
For Table of Content & Free Sample Report Contact:
Ajay Daniel
Email:
ajay.daniel@researchnester.com
U.S. +1 646 586 9123
U.K. +44 203 608 5919
No comments:
Post a Comment